Transfer pricing planning for the impacts of COVID-19

CRA was engaged by a global medical equipment company to analyze, help implement and defend the cross-border allocation of financial and tax impacts of the COVID-19 pandemic. The project included isolating applicable cost and revenue metrics in each jurisdiction and business segment, analyzing the economic consequences of the pandemic on distinct segments of the healthcare industry, and applying U.S. and international transfer pricing regulatory guidance.